CGTX Insider Trading Activity and SEC Form 4 Filings
CGTX insider trading summary
No open-market insider purchases or sales of Cognition Therapeutics Inc (CGTX) have been reported on SEC Form 4 in the past 12 months.
Latest CGTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 31, 2025 | Lisa Ricciardi | CEO & President | Buy | $30K (38,851 @ $0.77) |
| Mar 14, 2024 | Lisa Ricciardi | CEO & President | Buy | $10K (5,700 @ $1.75) |
| Nov 29, 2022 | Ellen B Richstone | Director | Buy | $27K (10,000 @ $2.65) |
| Nov 28, 2022 | BIOS Fund I, LP | Director | Buy | $5K (1,973 @ $2.65) |
| Nov 28, 2022 | Bios Equity Partners, LP | Director | Buy | $5K (1,973 @ $2.65) |
| Nov 28, 2022 | BIOS Advisors GP, LLC | Director | Buy | $5K (1,973 @ $2.65) |
| Nov 28, 2022 | Aaron G.L. Fletcher | Director | Buy | $5K (1,973 @ $2.65) |
| Nov 28, 2022 | BIOS Memory SPV I, LP | Director | Buy | $5K (1,973 @ $2.65) |
| Nov 28, 2022 | BIOS Capital Management, LP | Director | Buy | $5K (1,973 @ $2.65) |
| Nov 28, 2022 | BIOS Fund I QP, LP | Director | Buy | $5K (1,973 @ $2.65) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.